Replies to post #24859 on Dakshidin Corporation (DKSC)

[Robza73]

DEKOX (TM) TRADEMARK

https://trademark.trademarkia.com/au/trademark-1719335.htm

Last Applicant/Owner:
MEDIFRUIT PTY LTD

About GenBio Inc.
Based in Brisbane Australia, GenBio is a pharmaceutical and nutraceutical research company that employs a proprietary drug discovery platform to generate novel therapeutic agents for use in multiple distinct indications. GenBio leads a team of International Scientists in developing new pharmaceutical products in the fields of pain relief, arthritis, asthma, and infectious diseases.

The company's lead product under development, DEKOX(TM), is the first molecule in a new class of COX-2 selective / LOX-5 / LOX-15 triple inhibitors, protected with pending patents and owned exclusively.

The GenBio disruptive platform aims at the treatment of:

* Arthritis * Pain Relief * Inflammation * MRSA * Anti-Obesity * Anti-Aging Systems * Therapeutic * Irritable Bowel Syndrome * UTI * Asthma * Alzheimer’s